677 материалов по теме, собраны автоматически из проверенных источников
Black patients and people with a learning disability face longer waiting times at key stages of breast cancer care, according to a nationwide study led by the University of Surrey.
Biontech And Dualitybio Announce Topline Results Of Global Phase 3 Clinical Trial for Breast Cancer TradingView
Most advanced breast cancer patients treated in community settings, Phesi study finds Pharmafile
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer Carroll County Mirror-Democrat
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer WBOC TV
Рак молочной железы — не приговор: истории трёх армянских женщин — от страха до надежды АМИ "Новости-Армения"
ESMO26: An $8.4bn bispecific ADC doubles PFS in HR+/HER2- breast cancer Clinical Trials Arena
Pfizer Atirmociclib Breast Cancer Research Grants 2027: $8 Million Funding Pool Oncodaily
Personalized care, powered by innovation: How Ochsner is transforming breast cancer treatment The Advocate
Personalized care, powered by innovation: How Ochsner is transforming breast cancer treatment The Advocate
Evandro de Azambuja: Modest PFS Benefit With Pembrolizumab in Advanced Breast Cancer Oncodaily
Can a supplement help with brain fog after breast cancer treatment? Medical News Today